7 results
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
10 Aug 23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
with Searchlight Pharma in Canada, a leading commercial territory, over a fifteen-year term that is renewable for subsequent five-year periods,” stated Alon Seri … term that is renewable for subsequent five-year periods. As part of the agreement terms, Sol-Gel will receive up to $11 million in potential upfront
424B3
SLGL
Sol-Gel Technologies Ltd
10 Aug 23
Prospectus supplement
7:20am
, over a fifteen-year term that is renewable for subsequent five-year periods,” stated Alon Seri Levy, Ph.D., Chief Executive Officer of Sol-Gel. “Based … for the Canadian market. Partner Searchlight is to commercialize both products in Canada over a fifteen-year term that is renewable for subsequent five-year
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
6 Jun 23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to
7:15am
in the U.S., and Searchlight is to commercialize them in Canada over a fifteen-year term that is renewable for subsequent five-year periods.
TWYNEO
6-K
EX-99.2
SLGL
Sol-Gel Technologies Ltd
10 Aug 23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
, signed on an exclusive license agreements for TWYNEO and EPSOLAY for the Canadian market, over a fifteen-year term that is renewable for subsequent five
424B3
6eggi2jpo gg6o6u
4 Apr 24
Prospectus supplement
9:05am
POS AM
tcib x9r9lpheoaenu
20 Mar 24
Prospectus update (post-effective amendment)
4:05pm
- Prev
- 1
- Next